Nasdaq Biotechnology iShares Equity-NMS: IBB



Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$129.58
Open :$130.41
Today's high :$130.41
Today's low :$127.48
52W low :$111.83
52W high :$141.16
1Y :-2.52%
5Y :17.11%

Compare with Other ETFs

Frequently Asked Questions

What is Nasdaq Biotechnology iShares (IBB) price today?

The Nasdaq Biotechnology iShares (IBB) share price as of April 15, 2024 is $127.85. If you are investing from India, you can check the value in INR before investing.

Can I buy Nasdaq Biotechnology iShares (IBB) shares?

Yes, Indian investors can buy Nasdaq Biotechnology iShares (IBB) in the US stock market by opening an International Trading Account with Angel One.

How to buy Nasdaq Biotechnology iShares (IBB) Shares in India?

Indian investors can buy Nasdaq Biotechnology iShares (IBB) through the following modes:
  1. Direct investment: One can invest through opening an International Trading Account with Angel One. Once account is opened, you can add funds in U.S. dollars to buy Nasdaq Biotechnology iShares (IBB).
  2. Indirect investment: One can invest indirectly in Nasdaq Biotechnology iShares (IBB) through mutual funds and Exchange Traded Funds (ETFs) that offer exposure to global stocks.

Can I buy Fractional shares of Nasdaq Biotechnology iShares (IBB)?

Yes, you can buy a fraction of Nasdaq Biotechnology iShares (IBB). In Angel One, you can buy global stocks for any dollar value.

About Nasdaq Biotechnology iShares

iShares Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.